#truist
Latest news and interesting information about truist.
PKG CEO sells $2M in shares
Packaging Corp of America CEO Mark Kowlzan sold $2 million in shares. PKG stock trades at $218.14.
Truist Cuts Caesars Stock Rating on Deal
Truist Securities downgraded Caesars Entertainment after Fertitta Entertainment acquisition deal. Latest news and analysis.
Why is Carnival stock rallying today?
Carnival stock rallies 3.8% today as falling oil prices boost margins. Unhedged fuel exposure amplifies gains. Learn why CCL is rising.
Why Is MGM Resorts Stock Surging Today?
MGM Resorts stock surges 7.7% as JPMorgan and Truist Securities issue upgrades. Analyst upgrades and strong fundamentals drive the rally.
Burlington earnings: consumer pressures loom
Burlington Stores reports first-quarter earnings amid consumer pressure. Investors watch for signs of resilience against larger rivals.
Truist Cuts Zscaler Price Target to $200
Truist Securities cuts Zscaler price target to $200, maintains Buy rating. Conservative FY2027 outlook drives stock down 20%.
Truist Cuts Boston Properties Price Target on Rates
Truist Securities cuts Boston Properties target to $64 from $70, hold rating maintained. Higher rates and capex drive estimate reductions.
Truist Financial SWOT analysis: revenue headwinds
Truist Financial SWOT analysis: revenue headwinds, credit pressures, and share buyback program. 2026 projections and analyst ratings.
KeyBanc Reiterates Overweight on Walmart, $145 Target
KeyBanc reiterates Overweight on Walmart with $145 target. Walmart shows strong market share gains and digital momentum despite recent stock decline.
Truist Raises Keysight Price Target to $376 on Strong Orders
Truist Securities hikes Keysight price target to $376 after record quarterly orders with 48% growth. Stock up 111% in a year but premium valuation remains.
Truist raises Nvidia target to $307
Truist Securities boosts Nvidia price target to $307 from $287, reiterates Buy rating amid strong AI demand and growth prospects.
Truist Cuts Intuit Price Target
Truist Securities cuts Intuit price target to $410 from $500 but keeps Buy rating. TurboTax growth slows amid DIY filer weakness.
Truist cuts Lowe's price target to $255
Truist Securities cuts Lowe's price target to $255 from $280, maintaining Buy rating. Expense timing pressure expected to weigh on Q2 earnings.
Truist raises TJX price target to $190 on strong results
Truist Securities raises TJX price target to $190 on strong earnings and raised guidance, maintaining a Buy rating.
State Street SWOT: mixed outlook amid rising costs
State Street SWOT analysis: mixed outlook due to rising expenses and FX exposure, balanced by mandate backlog and margin expansion.
Evertec amends credit agreement, gets $185M
Evertec amends credit agreement, securing $185 million in new term loans. Total debt reaches $875 million.
Truist Raises Target Price Target to $130
Truist Securities raises Target price target to $130 after strong Q1 results. Comparable sales up 5.6%, earnings beat estimates.
William Blair Starts Insulet at Outperform
William Blair initiates Insulet at Outperform. Stock trades at 24x EPS, undervalued per Bond.az. Key concerns and catalysts detailed.
Commvault CFO Gary Merrill sells $323,864 in stock
Commvault CFO Gary Merrill sells $323,864 worth of stock. Details on recent transactions and company performance.
Truist Raises Acushnet Target to $97
Truist Securities boosts Acushnet price target to $97, citing healthy trends. Hold rating maintained. Read more on Bond.az.
Bill.com price target cut to $45 on take rate outlook
Truist Securities cuts Bill.com price target to $45 from $46, maintains Buy rating. Updated model reflects slower take rate expansion and cost-cutting measures.
Piper Sandler Reiterates Boston Scientific Buy Rating
Piper Sandler reiterated an Overweight rating on Boston Scientific. Agent DCB drives growth; stock undervalued per Bond.az.
Morgan Stanley Reiterates Home Depot Rating on Execution
Morgan Stanley reiterates Overweight rating on Home Depot with $420 target, citing solid execution in a growthless housing market.
Truist Starts Arcus Biosciences at Buy on RCC Potential
Truist Securities initiates Arcus Biosciences with Buy rating and $35 price target, citing casdatifan's potential in renal cell carcinoma and immunology pipeline.
Revolution stock buy rating from Truist
Truist Securities gives Revolution Medicines a buy rating with a $179 price target. Daraxon's potential and company outlook.
Fortinet CFO Sells $90,720 in Stock
Fortinet CFO Christiane Ohlgart sold $90,720 worth of stock near the 52-week high. The sale was part of a pre-arranged trading plan.
Texas Instruments senior VP sells $1.5m in shares
Texas Instruments Senior VP Ahmad Bahai sells $1.5 million in shares. Stock has surged 96% in six months.
Why Is DexCom Stock Surging Today?
DexCom stock surges 7.21% after Elliott Management stake and $1B buyback announcement. Analysts bullish on growth prospects.
Texas Instruments director sells $2.7m in stock
Texas Instruments director Carrie Smith Cox sold $2.7 million in stock. Shares near 52-week high.
Martin Marietta shareholders approve directors, stock plan
Martin Marietta shareholders approve directors, auditor, executive pay, and stock plan at annual meeting. Q1 results and analyst targets.
...